4//SEC Filing
KANEKO YASUNORI 4
Accession 0001209191-22-037409
CIK 0001724521other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:21 PM ET
Size
9.5 KB
Accession
0001209191-22-037409
Insider Transaction Report
Form 4
KANEKO YASUNORI
Director
Transactions
- Award
Common Stock
2022-06-14+4,100→ 4,100 total - Award
Stock Option (Right to Buy)
2022-06-14+16,800→ 16,800 totalExercise: $20.62Exp: 2032-06-13→ Common Stock (16,800 underlying)
Holdings
- 252,524(indirect: By LLC)
Common Stock
- 505,050(indirect: By LLC)
Common Stock
- 142,081(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents the grant of restricted stock units that vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- [F2]Includes 3,000 shares of restricted stock units (previously reported) that vested on June 3, 2022 and were subsequently transferred to the reporting person's trust.
- [F3]The option will vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001277503
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:21 PM ET
- Size
- 9.5 KB